In order to exclude the possibility that the observed effect of NEK4 was cell‐ and cancer‐type specific, we employed two more breast cancer cell lines, MDA‐MB‐231 and MCF7, to validate molecular effect of NEK4. Here, NEK4 is linked to breast carcinoma.